Raised viral load in patients with viral suppression on highly active antiretroviral therapy: transient increase or treatment failure?

Keywords

Viral load, Medicine, Viral disease, Antiretroviral therapy, Cohort

References

• Ultrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in PlasmaRita Sun, Joanne Ku, Harsha Jayakar — 1998
• Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infectionSabine Yerly, Thomas Perneger, Samir Vora — 2000
• Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug ResistanceJames W. Stuart, Annemarie M. J. Wensing, Colin Kovacs — 2001
• The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements. The Women Infant Transmission Study Clinics. Virology Quality Assurance Program.Donald Brambilla, Patricia Reichelderfer, James W. Bremer — 1999
• The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapyBharat Ramratnam, John E. Mittler, Linqi Zhang — 2000
• Decay characteristics of HIV-1-infected compartments during combination therapyAlan S. Perelson, Paulina Essunger, Yunzhen Cao — 1997
• Prevalence and predictive value of intermittent viremia with combination hiv therapy.Diane V. Havlir — 2001
• Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy.Huldrych F. Günthard, Joseph K. Wong, Celsa A. Spina — 2000
• Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionDavid L. Paterson, Susan Swindells, Jeffrey Mohr — 2000
• Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults.James C. King, John J. Treanor, Patricia Fast — 2000
• Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. U.S. Department of Health and Human Services (DHHS).&NA; — 1997
• Transient Relapses (“Blips”) of Plasma HIV RNA Levels During HAART Are Associated With Drug ResistanceJ. W. T. Cohen Stuart, Annemarie M. J. Wensing, Colin Kovacs — 2001

Cited by

• HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patientsSaadat M. Alhashmi — 2014
• A Control Theoretic Approach to HIV/AIDS Drug Dosage Design and Timing the Initiation of TherapyAnnah M. Jeffrey — 2006
• Multi-class support vector machines for modeling HIV/AIDS treatment adherence using patient dataZhao Lu, Hao Ying, Feng Lin — 2005
• Transient Viral Load Increases in HIV-Infected Children in the UK and Ireland: What do They Mean?Katherine J. Lee, Delane Shingadia, Deenan Pillay — 2007
• Human Immunodeficiency Virus (HIV)- Blood Interactions in Antiretroviral Drugs Environment—Surface Thermodynamics ApproachOkwuchukwu Innocent Ani, Sam N. Omenyi, C. H. Achebe — 2015
• Genotypic Resistance and Immunologic Outcomes Among HIV-1-Infected Women With Viral FailureStephen J. Gange, Michael F. Schneider, Robert M. Grant — 2006
• Persistent low‐level viraemia and virological failure in HIV‐1‐infected patients treated with highly active antiretroviral therapySomnuek Sungkanuparph, RK Groger, Edgar T. Overton — 2006
• The Clinical Interpretation of Viral Blips in HIV Patients Receiving Antiviral Treatment: Are We Ready to Infer Poor Adherence?Isaac Chun‐Hai Fung, Manoj Gambhir, Ard van Sighem — 2012
• Defining Treatment Failure in Resource-Rich SettingsJeannette L. Aldous, Richard Haubrich — 2009
• Temporal Association Between Incident Tuberculosis and Poor Virological Outcomes in a South African Antiretroviral Treatment ServiceAnkur Gupta‐Wright, Robin Wood, Linda‐Gail Bekker — 2013
• Intermittent HIV-1 Viremia (Blips) and Virological Failure in a Cohort of People Living with HIV from São Paulo, BrazilKarim Yaqub Ibrahim, Patrícia Recordon-Pinson, Denis Malvy — 2012
• The Significance of HIV Viral Load Assay Precision: A Review of the Package Insert Specifications of Two Commercial KitsDavid Chernoff — 2002
• Gender Differences in HIV-1 RNA Rebound Attributed to Incomplete Antiretroviral Adherence Among HIV-Infected Patients in a Population-Based CohortLaura M. Kuyper, Evan Wood, Julio Montaner — 2004
• Influence of a Vaccination Schedule on Viral Load Rebound and Immune Responses in Successfully Treated HIV-Infected PatientsPedro Castro, Montserrat Plana, Raquel González — 2009
• HIV viral load: the myth of the undetectable?Deenan Pillay — 2002
• Plasma levels of B-lymphocyte stimulator increase with HIV disease progressionBenigno Rodríguez, Hernán Valdez, William W. Freimuth — 2003
• No evidence of an association between transient HIV viremia ("Blips") and lower adherence to the antiretroviral medication regimen.Loren G. Miller, Carol E. Golin, Honghu Liu — 2004
• Definition of loss of virological response in trials of antiretroviral drugsSchlomo Staszewski, Caroline Sabin, Brenda Dauer — 2003
• Drug switching and virologic-based endpoints in trials of antiretroviral drugs for HIV infectionAndrew Phillips, A Sarah Walker — 2004
• The Significance of Low-Level Plasma HIV Viral Load on COBAS TaqMan® HIV-1 Assays for Patients with Undetectable Plasma Viral Load on COBAS Amplicor® Monitor Version 1.5K Manavi — 2008

Related papers

• HIV RNA level in early infection is predicted by viral load in the transmission sourceFrederick Hecht, Wendy Hartogensis, Larry Bragg — 2010
• Lower human immunodeficiency virus (HIV) type 2 viral load reflects the difference in pathogenicity of HIV-1 and HIV-2.Stephen J. Popper, Abdoulaye Dieng Sarr, Karin Travers — 1999
• Estimation of the Predictive role of Plasma Viral load on CD4 decline in HIV-1-subtype C infected subjects in IndiaMing Ding, Patrick M. Tarwater, Milka A. Rodriguez — 2009
• Effect of hemodialysis and antiretroviral therapy on plasma viral load in HIV-1 infected hemodialysis patients.Taniya Ahuja, Nimra Niaz, A. Velasco — 1999
• Predictive value of viral load measurements in asymptomatic untreated HIV‐1 infection: a mathematical modelJohn P. A. Ioannidis, Joseph C. Cappelleri, Joseph W.Y. Lau — 1996
• Comparison of Two Measures of Human Immunodeficiency Virus (HIV) Type 1 Load in HIV Risk GroupsCynthia M. Lyles, David Vlahov, Homayoon Farzadegan — 1998
• Cytomegalovirus viral load monitoring after allogeneic bone marrow transplantation in patients receiving antiviral prophylaxisBenjamin P. Howden, Alexander Michaelides, Denis W. Spelman — 2003